HOLX's GYN Surgical unit, boosted by MyoSure, Fluent and Gynesonics, drives 10.2% revenue growth and is likely to lift ...
Hologic, Inc. HOLX GYN Surgical is expected to have registered vital contributions from MyoSure and the Related fluid system, with an increasing contribution from its laparoscopic portfolio. Moreover, ...
On Monday, Hologic Inc (NASDAQ:HOLX) agreed to acquire Gynesonics, Inc. for approximately $350 million. Gynesonics is a privately held medical device company that develops minimally invasive solutions ...
Zacks Investment Research on MSN
HOLX vs. SYK: Which medical device leader is a solid bet now?
The global medical device industry is characterized by rapid technological advances, innovations and scientific discoveries.
The global Gynecological Devices market is expanding, supported by the higher prevalence of diseases like PCOS, uterine fibroids and cervical cancer, continued innovation in minimally invasive ...
Analyst Michael Ryskin of Bank of America Securities reiterated a Hold rating on Hologic (HOLX – Research Report), boosting the price target to $82.00. Michael Ryskin has given his Hold rating due to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results